Cockcroft-Gault Formula: Creatinine Clearance Calculator

The Cockcroft-Gault Formula: Assessing Renal Function and Adjusting Dosages

Published in 1976, the Cockcroft-Gault formula remains a landmark equation in nephrology and clinical pharmacology. It is widely used to estimate creatinine clearance (CrCl) in mL/min, a key indicator of the glomerular filtration rate (GFR) and the kidneys' ability to clear metabolic waste.

What is the clinical utility of this calculation?

While newer equations (like CKD-EPI or MDRD) are currently preferred for screening Chronic Kidney Disease (CKD), the Cockcroft-Gault equation remains the absolute "Gold Standard" for drug dose adjustment. The vast majority of pharmaceutical monographs (especially for antibiotics like Vancomycin, or Direct Oral Anticoagulants - DOACs) rely exclusively on this formula to dictate renal dosing.

• Physiological parameters: The calculation incorporates age, weight, and serum creatinine, applying a 0.85 correction factor for females (due to physiologically lower muscle mass).
• Clinical Limitations (LSI): Because this formula is not indexed to standard body surface area (1.73 m²), it may overestimate clearance in obese patients (where ideal body weight should be considered) and underestimate it in elderly or malnourished patients (sarcopenia).

Stages of Renal Impairment (KDIGO Equivalents)

Clearance (mL/min)	Stage (Renal Function)	Clinical Action (Dosing)
≥ 90	Normal	Standard dosing.
60 - 89	Mild impairment	Usually no major adjustment.
30 - 59	Moderate impairment	Dose adjustment recommended.
15 - 29	Severe impairment	Strict adjustment or contraindication.
< 15	End-Stage Renal Disease	Dialysis, highly specific dosing.

---

References:

1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. [Karger Publishers]
2. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013. [KDIGO Official]